II. Development and future prospects of the third-generation EGFR-tyrosine kinase inhibitor

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

本文言語	英語
ページ（範囲）	935-939
ページ数	5
ジャーナル	Japanese Journal of Cancer and Chemotherapy
巻	42
号	8
出版ステータス	出版済み - 8月 2015

All Science Journal Classification (ASJC) codes

この成果は、次の持続可能な開発目標に貢献しています

@article{5c738e0cb29b4d909e4c4ac06eb3f32d,

title = "II. Development and future prospects of the third-generation EGFR-tyrosine kinase inhibitor",

author = "Shinya Sakata and Eiji Iwama and Isamu Okamoto",

year = "2015",

month = aug,

language = "English",

volume = "42",

pages = "935--939",

journal = "Japanese Journal of Cancer and Chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "8",

}

TY - JOUR

T1 - II. Development and future prospects of the third-generation EGFR-tyrosine kinase inhibitor

AU - Sakata, Shinya

AU - Iwama, Eiji

AU - Okamoto, Isamu

PY - 2015/8

Y1 - 2015/8

UR - http://www.scopus.com/inward/record.url?scp=84978382729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978382729&partnerID=8YFLogxK

M3 - Article

C2 - 26353390

AN - SCOPUS:84978382729

VL - 42

SP - 935

EP - 939

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 8

ER -